fluoxymesterone
Term · Oncology and biomedicine · MLC-T-ONC-013730
A halogenated derivative of 17-alpha-methyltestosterone. Similar to testosterone, fluoxymesterone binds to and activates specific nuclear receptors, resulting in an increase in protein anabolism, a decrease in amino acid catabolism, and retention of nitrogen, potassium, and phosphorus. This agent also may competitively inhibit prolactin receptors and estrogen receptors, thereby inhibiting the growth of hormone-dependent tumor lines. Fluoxymesterone is approximately five times more potent than methyltestosterone.
| Identifier | MLC-T-ONC-013730 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | FXM |
| Synonyms | Androfluorene; Androsterolo |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013730",
"term": "fluoxymesterone",
"field": "Oncology and biomedicine",
"definition": "A halogenated derivative of 17-alpha-methyltestosterone. Similar to testosterone, fluoxymesterone binds to and activates specific nuclear receptors, resulting in an increase in protein anabolism, a decrease in amino acid catabolism, and retention of nitrogen, potassium, and phosphorus. This agent also may competitively inhibit prolactin receptors and estrogen receptors, thereby inhibiting the growth of hormone-dependent tumor lines. Fluoxymesterone is approximately five times more potent than methyltestosterone.",
"abbreviation": "FXM",
"synonyms": [
"Androfluorene",
"Androsterolo"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/fluoxymesterone/"
}
Record 7,495 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.